本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Quoin Pharmaceuticals

6.10
-0.5050-7.65%
盘后6.100.00000.00%19:29 EDT
成交量:3.19万
成交额:20.23万
市值:358.78万
市盈率:-0.09
高:7.09
开:6.67
低:6.00
收:6.61
数据加载中...
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals